Content and sulfation pattern of keratan sulfate in hip osteoarthritis using high performance liquid chromatography

Journal of Rheumatology

Volumn 27, Issue 7, 2000, Pages 1721-1724

  Yamada, Harumoto ^a   Miyauchi, Satoshi ^b   Morita, Mitsuhiro ^b   Yoshida, Yuko ^b   Yoshihara, Yasuo ^b   Kikuchi, Toshiyuki ^b   Washimi, Osuke ^b   Washimi, Yuki ^b   Terada, Nobuki ^b   Seki, Tsuneo ^b   Fujikawa, Kyosuke ^b  

^a FUJITA HEALTH UNIVERSITY   (Japan)

^b NONE

Author keywords

High performance liquid chromatography; Joint marker; Keratan sulfate; Osteoarthritis; Sulfation; Synovial fluid

Indexed keywords

KERATAN SULFATE; N ACETYLGLUCOSAMINE;

ARTICLE; CARTILAGE MATRIX; COXITIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; JOINT RADIOGRAPHY; PRIORITY JOURNAL; SULFATION; SYNOVIAL FLUID;

ADULT; AGED; BIOLOGICAL MARKERS; CARTILAGE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISACCHARIDES; FEMALE; HUMANS; KERATAN SULFATE; MALE; MIDDLE AGED; OSTEOARTHRITIS, HIP; SULFUR; SYNOVIAL FLUID;

EID: 0033940840     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Thonar EJ-MA, Shinmei M, Lohmander LS. Body fluid markers of cartilage changes in osteoarthritis. In: Moskowitz RW, editor. Rheumatic Disease Clinics of North America. Philadelphia: WB Saunders; 1993:635-57.
2. Lohmander LS. Articular cartilage and osteoarthritis. The role of molecular markers to monitor breakdown, repair and disease. J Anat 1994;184:477-92.
3. Dahlberg L, Ryd L, Heinegård D, Lohmander LS. Proteoglycan fragments in joint fluid. Influence of arthrosis and inflammation. Acta Orthop Scand 1992;63:417-23.
4. Carroll G. Measurement of sulphated glycosaminoglycans and proteoglycan fragments in arthritic synovial fluid. Ann Rheum Dis 1989;48:17-24.
5. Thonar EJ-MA, Lenz ME, Kuettner K, et al. Quantification of keratan sulfate in blood as a marker of cartilage catabolism. Arthritis Rheum 1985;28:1367-76.
6. Campion GV, McCrae F, Schnitzer TJ, Lenz ME, Dieppe PA, Thonar EJ-MA. Levels of keratan sulfate in the serum and synovial fluid of patients with osteoarthritis of the knee. Arthritis Rheum 1991;34:1254-9.
7. Mehmet H, Scudder P, Tang PW, Hounsell EF, Caterson B, Feizi T. The antigenic determinants recognized by three monoclonal antibodies to keratan sulfate involve sulfated hepta- or larger oligosaccharides of the poly(N-acetyllactosamine) series. Eur J Biochem 1986;157:385-91.
8. Carroll G, McCappin S, Bell MC, Schwarzer A, Breidahl P. Comparison of keratan sulphate concentrations and the size distribution of proteoglycans in the synovial fluid of patients with osteoarthritis and pyrophosphate arthropathy. Rheumatol Int 1991;11:63-8.
9. Thonar EJ-MA, Manicourt DH, Williams JM, et al. Serum keratan sulfate: a measure of cartilage proteoglycan metabolism. In: Kuettner K, Schleyerbach R, Peyron JG, Hascall VC, editors. Articular cartilage and osteoarthritis. New York: Raven Press; 1992:429-45.
10. Carroll GJ, Bell MC, Laing BA, McCappin S, Blumer C, Leslie A. Reduction of the concentration and total amount of keratan sulphate in synovial fluid from patients with osteoarthritis during treatment with piroxicam. Ann Rheum Dis 1992;51:850-4.
11. Thonar EJ-MA, Williams JM, Maldonado BA, et al. Serum keratan sulfate concentration as a measure of the catabolism of cartilage proteoglycans. In: Kresina TF, editor. Monoclonal antibodies, cytokines, and arthritis. New York: Marcel Dekker; 1991:373-98.
12. Shinmei M, Miyauchi S, Machida A, Miyazaki K. Quantitation of chondroitin 4-sulfate and chondroitin 6-sulfate in pathologic joint fluid. Arthritis Rheum 1992;35:1304-8.
13. Yoshida K, Miyauchi S, Kikuchi H, Tawada A, Tokuyasu K. Analysis of unsaturated disaccharides from glycosaminoglycan by high-performance liquid chromatography. Anal Biochem 1989;177:327-32.
14. Altman R, Alarcón G, Appelrouth D, et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum 1991;34:505-14.
15. Shima Y, Ueno R. Comparison of the therapies for osteoarthritis of the hip joint. Evaluation for the clinical result and long term result. Nippon Seikeigekagakkai Zasshi (J Jap Orthop Assoc) 1971;45:813-33 [in Japanese].
16. Toyoda H, Shinomiya K, Yamanashi S, Koshiishi I, Imanari T. Microdetermination of unsaturated disaccharides produced from chondroitin sulfates in rabbit plasma by high performance liquid chromatography with fluorometric detection. Anal Sci 1988;4:381-4.
17. Nakazawa K, Ito M, Yamagata T, Suzuki S. Substrate specificity of keratan sulfate degrading enzymes (endo-B-galactosidase, keratanase and keratanase II) from microorganisms. In: Greiling H, Scott JE, editors. Keratan sulfate. Chemistry, biology, and chemical pathology. London: The Biochemical Society; 1989;99-110.
18. Honda S, Konishi T, Suzuki S. Electrochemical detection of reducing carbohydrates in high-performance liquid chromatography after post-column derivatization with 2-cyanoacetamide. J Chromatogr 1984;299:245-51.
19. Yamada H, Miyauchi S, Hotta H, et al. Levels of chondroitin sulfate isomers in the synovial fluids from patients with hip osteoarthritis. J Orthop Sci 1999;4:250-4.
20. Israel HA, Saed-Nejad F, Ratcliffe A. Early diagnosis of osteoarthritis of the temporomandibular joint: correlations between arthroscopic diagnosis and keratan sulfate levels in the synovial fluid. J Oral Maxillofac Surg 1991;49:708-11.
21. Sharif M, Osborne DJ, Meadows K, et al. The relevance of chondroitin and keratan sulfate markers in normal and arthritic synovial fluid. Br J Rheumatol 1996;35:951-7.